Ashish Kacholia Portfolio: Specialty Chemical Stock Sees Stock Surge; Here's Why

Fineotex Chemical Limited (FCL) displayed commendable performance by obtaining government permission for its new antioxidant mosquito control solution, AquaStrike Premium. This product, which is an export formulation, has been registered by the Central Insecticide Board as a product of Azadirachtin's pack-selling and importing formulation. This achievement enhances FCL's efforts toward public health and environmental protection through the introduction of safe and highly effective substitutes for traditional mosquito control methods.

AquaStrike Premium has no odour and becomes visible only in water. It is an amazing and imperceptible liquid that is sprinkled onto water surfaces to kill mosquito larvae. It also employs European technology. AquaStrike Premium is unlike conventional insecticides because it does not need to be sprayed and it improves the quality of water. The product is backed by several international certifications including the Malaysian Ministry of Health and Singapore's Public Utility Board. FCL intends to work with other government departments, NGOs, healthcare bodies, and programs to facilitate broad-spectrum mosquito control programs within the country, India so that the targeted communities are much healthier.

Alongside its progress in public health solutions, FCL has done well to further cement its position in the oil & gas as well as water treatment industries where growth is likely. The company is well positioned with a healthy order book in multiple locations as well as with the construction of a new plant in Ambernath. This new facility, which is anticipated to be operational by Q2 of FY26, will enhance the company's total production capacity considerably. While this is going on, FCL is innovating and has launched 15 new products this quarter, one of which is the premium sustainable solution AquaStrike. Having set aside more than Rs 300 crores for inorganic growth, the company is actively looking for strategic acquisitions to expand its market reach.

FCL has performed well in the capital market and maintained sales growth with profit margins over a number of years. The quarterly results indicate that net sales for Q3 FY25 came in at Rs 125.92 crore, representing a decrease of 9% from Q3 FY24, while net profit also decreased by 15% to Rs 27.63 crore. In the first nine months of FY25, net sales remained almost stable and dipped 1% to Rs 413.55 crore, and net profit decreased by 2% coming in at Rs 89.08 crore when compared to the previous FY25. To further strengthen its financial position, FCL has given an interim dividend of Rs 0.40 per share which amounts to Rs 4.58 crore. In addition, FCL's is now rated A+ Positive by ICRA, on both long and short-term instruments, demonstrating favorable capital position.

Notable investments have been made by Ashish Kacholia who controls 2.74% of the company which translates to 31,35,568 shares as of December 2024. The company's market cap is 3000 crore FCL has also reported a remarkable 880% increase in shares within the last five years. This mark coincides with the company's astounding return on equity ROE estimated at 30% and return on capital employed ROCE standing at 39%.

In July 2024, Fineotex Chemical Ltd successfully raised Rs 342.5 crore through a preferential allotment of equity shares and convertible warrants. This fund-raising was carried out in two phases, demonstrating strong investor demand and bolstering the company's financial standing.

Phase I of the fundraising involved the allotment of 9,70,000 equity shares at an issue price of Rs 346 per share, raising Rs 33.56 crore. Additionally, 26,26,600 convertible warrants were issued at the same price, aggregating Rs 90.88 crore. The company received an upfront payment of Rs 22.72 crore, representing 25% of the total warrant issue size. Each warrant can be converted into one fully paid equity share upon payment of the remaining Rs 259.50 per warrant within 18 months of May 22, 2024.

Phase II of the fundraising saw the issuance of 28,15,049 equity shares at Rs 387.40 per share, raising Rs 109.05 crore. Similarly, 28,15,049 convertible warrants were issued at the same price, aggregating Rs 109.05 crore. The company received an upfront payment of Rs 27.26 crore, representing 25% of the warrant issue size, with each warrant convertible upon payment of Rs 290.55 per warrant within 18 months of July 19, 2024.

Fineotex Chemical Ltd has also made significant strides in strengthening its financial position, notably reducing debt and achieving strong profit growth. Over the past five years, the company's compound annual growth rate (CAGR) for profit has been an impressive 39.8%, reflecting its consistent financial success. This positive trend continued into the first quarter of FY25, with strong quarterly results, alongside robust annual performance for FY24.

Founded in 1979, Fineotex Chemical Ltd is a prominent manufacturer of specialty chemicals, primarily serving the textile industry. The company focuses heavily on research and development, particularly through its subsidiary, Biotex Malaysia. Fineotex's product portfolio spans over 470 categories, covering chemicals for various stages of textile production, oil and water-based drilling fluids, and home care disinfectants. The company also offers cleaning and hygiene products, including sanitizers and detergents.

With a presence in over 70 countries and a network of more than 100 dealers, Fineotex serves major clients like Nahar Group and Raymond in the textile sector. Fineotex Chemical is among the portfolio stocks of Ashish Kacholia in which the ace investor held 31,35,568 equity shares of the company comprising 2.74% fully-paid up share capital of the company.